Clinical Trial Update: Phase Ib/IIa Clinical Study of ACC017 Tablets [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase Ib/IIa trial evaluating ACC017 tablets for human immunodeficiency virus infection. Recruitment is currently open.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• ACC017

Snippet

Sponsor: Jiangsu Aidea Pharmaceutical Group Co., Ltd. | Conditions: Infection, Human Immunodeficiency Virus | Phase 1, Phase 2 | Status: RECRUITING